Cargando…

Vaccination and Pertussis

Detalles Bibliográficos
Autor principal:	Fink, Lawrence G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thacker 1908
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5183073/ https://www.ncbi.nlm.nih.gov/pubmed/29006553

Ejemplares similares

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015)

Vaccination in India
por: Fink, Lawrence G.
Publicado: (1910)

Specific Biological Diagnoses Are Needed to Determine the Durability of Pertussis Vaccine–Induced Immunity
por: Guiso, Nicole
Publicado: (2012)

Analysis of prevailing pertussis strains from different regions in China after the application of acellular vaccines
por: Liu, Yamin, et al.
Publicado: (2023)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

Pertussis Toxin: A Key Component in Pertussis Vaccines?
por: Gregg, Kelsey A., et al.
Publicado: (2019)

The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain
por: Godoy, Pere, et al.
Publicado: (2022)

The effect of maternal pertussis vaccination on the epidemiology of pertussis in Spain
por: Godoy, Pere, et al.
Publicado: (2022)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
por: Markey, Kevin, et al.
Publicado: (2019)

Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with Bordetella pertussis: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria
por: Tahar djebbar, Khedidja, et al.
Publicado: (2022)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
por: Esposito, Susanna, et al.
Publicado: (2019)

Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis
por: Ma, Longhuan, et al.
Publicado: (2021)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
por: Knuutila, Aapo, et al.
Publicado: (2023)

Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
por: Abu-Raya, Bahaa, et al.
Publicado: (2018)

Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
por: Hara, Megumi, et al.
Publicado: (2015)

The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam
por: Maertens, Kirsten, et al.
Publicado: (2016)

Pearl Kendrick, Grace Eldering, and the Pertussis Vaccine
por: Shapiro-Shapin, Carolyn G.
Publicado: (2010)

Pertussis models to inform vaccine policy
por: Campbell, Patricia T, et al.
Publicado: (2015)

Seroprevalence of pertussis in Madagascar and implications for vaccination
por: Razafimahatratra, Solohery L., et al.
Publicado: (2020)

Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines
por: Zomer, Aldert, et al.
Publicado: (2018)

Modification of innate immune responses to Bordetella pertussis in babies from pertussis vaccinated pregnancies
por: Rice, Thomas F., et al.
Publicado: (2021)

Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice
por: Holubová, Jana, et al.
Publicado: (2020)

Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis Initiative
por: Abu-Raya, Bahaa, et al.
Publicado: (2022)

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
por: van Schuppen, Evi, et al.
Publicado: (2022)

Immune response to pertussis vaccine in COPD patients
por: Feredj, E., et al.
Publicado: (2023)

Update on pertussis and pertussis immunization
por: Hong, Jung Yun
Publicado: (2010)

Seroprevalence of Pertussis in The Gambia: Evidence for Continued Circulation of Bordetella pertussis Despite High Vaccination Rates
por: Scott, Susana, et al.
Publicado: (2015)

153. The Effect of Timing of Tetanus–Diphtheria and Pertussis Vaccine Administration in Pregnancy on The Avidity of Pertussis Antibodies
por: Raya, Bahaa Abu, et al.
Publicado: (2018)

Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from Bordetella pertussis
por: Boehm, Dylan T., et al.
Publicado: (2019)

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
por: Abu-Raya, Bahaa, et al.
Publicado: (2019)

Fha Deficient Bordetella pertussis Isolates in Iran with 50 Years Whole Cell Pertussis Vaccination
por: Saedi, Samaneh, et al.
Publicado: (2021)

Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014–2018
por: Tessier, Elise, et al.
Publicado: (2020)

Erratum to: Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
Publicado: (2021)

Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice
por: Wolf, M. Allison, et al.
Publicado: (2021)

A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis
por: Gao, Jingjing, et al.
Publicado: (2023)

Maternal acellular pertussis vaccination in mice impairs cellular immunity to Bordetella pertussis infection in offspring
por: Dubois, Violaine, et al.
Publicado: (2023)

Roads to the development of improved pertussis vaccines paved by immunology
por: Brummelman, Jolanda, et al.
Publicado: (2015)

Effect of Vaccination on Bordetella pertussis Strains, China
por: Zhang, Liu, et al.
Publicado: (2010)

Pertussis re-emergence in the post-vaccination era
por: Chiappini, Elena, et al.
Publicado: (2013)

Acellular Pertussis Vaccine Components: Today and Tomorrow
por: Dewan, Kalyan K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ucvqs8oho45g269e2e3sfh9mmc